reboxetine has been researched along with tranylcypromine in 5 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (tranylcypromine) | Trials (tranylcypromine) | Recent Studies (post-2010) (tranylcypromine) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 1,826 | 94 | 183 |
| Protein | Taxonomy | reboxetine (IC50) | tranylcypromine (IC50) |
|---|---|---|---|
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 4.64 | |
| Cytochrome P450 1A1 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 2E1 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 3.585 | |
| Cytochrome P450 2C8 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 2A6 | Homo sapiens (human) | 2.7133 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 3.38 | |
| Cytochrome P450 4B1 | Homo sapiens (human) | 6.2 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.078 | |
| Cytochrome P450 2B6 | Homo sapiens (human) | 6.4533 | |
| Cytochrome P450 3A5 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 2A7 | Homo sapiens (human) | 6.2 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.29 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 3.6436 | |
| Cytochrome P450 3A7 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 2F1 | Homo sapiens (human) | 6.2 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.0871 | |
| Cytochrome P450 2C18 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 4.87 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 4F2 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 4F8 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 4A11 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 4F3 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 2A13 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 4A22 | Homo sapiens (human) | 6.2 | |
| Vitamin D 25-hydroxylase | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 2U1 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 2W1 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 2S1 | Homo sapiens (human) | 6.2 | |
| Cytochrome P450 3A43 | Homo sapiens (human) | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castelli, MG; Cicioni, P; Dostert, P; Strolin Benedetti, M | 1 |
| Duman, RS; Eisch, AJ; Malberg, JE; Nestler, EJ | 1 |
| Brunner, H; Friess, E; Pollmächer, T; Wichniak, A | 1 |
| Carey, GJ; Gold, LH; Nielsen, DM | 1 |
| Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J | 1 |
1 trial(s) available for reboxetine and tranylcypromine
| Article | Year |
|---|---|
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid | 2007 |
4 other study(ies) available for reboxetine and tranylcypromine
| Article | Year |
|---|---|
Reboxetine prevents the tranylcypromine-induced increase in tyramine levels in rat heart.
Topics: Animals; Dose-Response Relationship, Drug; Heart Rate; Male; Morpholines; Myocardium; Rats; Rats, Sprague-Dawley; Reboxetine; Time Factors; Tranylcypromine; Tyramine | 1994 |
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.
Topics: Animals; Antidepressive Agents; Antigens, Differentiation; Bromodeoxyuridine; Cell Count; Cell Division; Cell Survival; Fluorescent Antibody Technique; Fluoxetine; Hippocampus; Male; Morpholines; Neurons; Rats; Rats, Sprague-Dawley; Reboxetine; Tranylcypromine | 2000 |
Successful suppression of cataplectic attacks with tramadol.
Topics: Aged; Biogenic Monoamines; Cataplexy; Female; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Morpholines; Narcotics; Reboxetine; Receptors, Opioid; Recurrence; Sleep, REM; Substance Withdrawal Syndrome; Tramadol; Tranylcypromine; Treatment Outcome | 2003 |
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.
Topics: Animals; Antidepressive Agents; Clorgyline; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Hindlimb Suspension; Male; Mice; Morpholines; Motor Activity; Paroxetine; Pyrazoles; Pyrimidines; Pyrroles; Reboxetine; Receptors, Corticotropin-Releasing Hormone; Selegiline; Swimming; Tranylcypromine; Triazines | 2004 |